Smith M C, Furman T C, Ingolia T D, Pidgeon C
Biochemistry Research, Lilly Research Laboratories, Indianapolis, Indiana 46285.
J Biol Chem. 1988 May 25;263(15):7211-5.
We report our experimental results supporting the hypothesis that a specific metal-chelating peptide (CP) on the NH2 terminus of a protein can be used to purify that protein using immobilized metal ion affinity chromatography (IMAC). The potential utility of this approach resides with recombinant proteins since the nucleotide sequence that codes for the protein can be extended to include codons for the chelating peptide and thereby generate the gene for a chimeric CP-protein that can be cloned, expressed, and affinity-purified with immobilized metal ions. The chelating peptide purification handle could then be removed chemically or enzymatically after purification has been achieved to generate a protein with the natural amino acid sequence. The feasibility of using a chelating peptide as a purification handle has been demonstrated using a leuteinizing hormone-releasing hormone (LHRH) analog, 2-10 LHRH, which contains the previously identified chelating peptide, His-Trp, on the NH2 terminus. 2-10 LHRH had a high affinity for a Ni(II) IMAC column due to the NH2-terminal dipeptide sequence His-Trp, forming a coordination complex with Ni(II), whereas the controls, 3-10 LHRH and 4-10 LHRH, lacking the CP sequence, did not bind. Furthermore, 2-10 LHRH could be purified from a mixture of histidine-containing peptides on a Ni(II) IMAC column in one step. His-Trp proinsulin was used as a model of a recombinant CP-protein. The S-sulfonates of His-Trp-proinsulin and proinsulin were isolated from Escherichia coli engineered to overproduce these proteins as trpLE' fusion proteins. His-Trp-proinsulin(SSO3-)6 had a higher affinity for immobilized Ni(II) than proinsulin (SSO3-)6. Both proteins were eluted by decreasing the pH or by introducing a displacing ligand into the buffer. Ni(II) eluted from the column with much higher concentrations of displacing ligand than the proteins.
我们报告了实验结果,支持这样一种假说:蛋白质氨基末端的特定金属螯合肽(CP)可用于通过固定化金属离子亲和色谱法(IMAC)纯化该蛋白质。这种方法的潜在用途在于重组蛋白,因为编码该蛋白的核苷酸序列可以扩展,以包含螯合肽的密码子,从而产生嵌合CP-蛋白的基因,该基因可被克隆、表达,并通过固定化金属离子进行亲和纯化。在完成纯化后,螯合肽纯化标签可以通过化学或酶法去除,以产生具有天然氨基酸序列的蛋白质。使用促黄体生成激素释放激素(LHRH)类似物2-10 LHRH证明了使用螯合肽作为纯化标签的可行性,该类似物在氨基末端含有先前鉴定的螯合肽His-Trp。由于氨基末端二肽序列His-Trp,2-10 LHRH对Ni(II)IMAC柱具有高亲和力,与Ni(II)形成配位络合物,而缺乏CP序列的对照物3-10 LHRH和4-10 LHRH不结合。此外,2-10 LHRH可以在Ni(II)IMAC柱上一步从含组氨酸的肽混合物中纯化出来。His-Trp胰岛素原用作重组CP-蛋白的模型。His-Trp-胰岛素原和胰岛素原的S-磺酸盐从经过基因工程改造以过量生产这些蛋白作为trpLE'融合蛋白的大肠杆菌中分离出来。His-Trp-胰岛素原(SSO3-)6对固定化Ni(II)的亲和力高于胰岛素原(SSO3-)6。两种蛋白都通过降低pH值或在缓冲液中引入置换配体来洗脱。从柱上洗脱Ni(II)所需的置换配体浓度比蛋白高得多。